Last $62.96 USD
Change Today +0.33 / 0.53%
Volume 141.4K
BCPC On Other Exchanges
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

balchem corp (BCPC) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/2/14 - $66.34
52 Week Low
05/1/13 - $41.56
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BALCHEM CORP (BCPC)

Related News

No related news articles were found.

balchem corp (BCPC) Related Businessweek News

No Related Businessweek News Found

balchem corp (BCPC) Details

Balchem Corp. develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, and medical sterilization industries, primarily in the U.S. Its encapsulated/nutritional products segment provides solutions to various applications in food, pharmaceutical, and nutritional ingredients. It also offers human-grade choline nutrient products for wellness applications and calcium carbonate products, as well as products for the animal health industry. Its specialty products segment is a leader in packaging and distributing hazardous chemicals and is the leading supplier of packaged 100% ethylene oxide to the health-care industry, where it is used as a sterilant for medical items. The Ingredients segment manufactures and supplies choline chloride, a nutrient for animal health, to the poultry and swine industries. It also manufactures derivatives of choline chloride. Balchem was founded in 1967 and is headquartered in New Hampton, N.Y.

387 Employees
Last Reported Date: 02/27/14
Founded in 1967

balchem corp (BCPC) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $622.2K
Chief Financial Officer, Treasurer and Assist...
Total Annual Compensation: $243.0K
General Counsel and Secretary
Total Annual Compensation: $197.0K
Vice President of Arc Specialty Products and ...
Total Annual Compensation: $242.0K
Compensation as of Fiscal Year 2012.

balchem corp (BCPC) Key Developments

Balchem Corp. Announces Amended and Restated Bylaws, Effective April 1, 2014

Balchem Corp. announced that on March 28, 2014, the company's Bylaws were amended and restated effective April 1, 2014. The changes made in the bylaws were in Article III, Section 2 to decrease the number of directors from seven to six in light of the resignation of Dr. Wedral. The company intends to continue to preserve the number of directors in each class to be as nearly equal as practicable and in that regard promptly will commence a director evaluation process to regain that balance.

Elaine R. Wedral Intends to Retire as Director of Balchem Corporation, Effective from April 1, 2014

On March 25, 2014, Dr. Elaine R. Wedral, notified Balchem Corporation of her intention to retire as a director of the company, effective April 1, 2014.

Balchem Corp. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2013; Provides Capital Expenditures Guidance for 2014

Balchem Corp. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2013. For the quarter, the company reported net sales of $81,633,000 against $80,060,000 a year ago. Earnings from operations were $16,145,000 against $15,037,000 a year ago. Earnings before income tax expense were $16,213,000 against $15,107,000 a year ago. Net earnings were $10,747,000 or $0.35 per diluted share against $9,892,000 or $0.33 per diluted share a year ago. The company generated approximately $18.8 million in EBITDA in the quarter, which translates into $0.61 per diluted share and when including the company's non-cash stock based compensation charge, the company generated $19.7 million of EBITDA or 24% of sales in the quarter equaling approximately $0.64 per share. For the full year, the company reported net sales of $337,173,000 against $310,393,000 a year ago. Earnings from operations were $65,602,000 against $59,777,000 a year ago. Earnings before income tax expense were $65,818,000 against $59,844,000 a year ago. Net earnings were $44,874,000 or $1.45 per diluted share against $40,005,000 or $1.32 per diluted share a year ago. Net cash provided by operating activities was $55,692,000 against $53,781,000 a year ago. Capital expenditures were $8,187,000 against $13,883,000 a year ago. Intangible assets acquired were $230,000 against $121,000 a year ago. The company provided capital expenditures guidance for 2014. For 2014, annualized effective income tax rate is currently estimated to be approximately 33%. Capital expenditures are expected to be approximately $20 million, including key projects for energy savings in Europe, additional plant expansion and participation in the production JV with Taminco.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BCPC:US $62.96 USD +0.33

BCPC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
American Vanguard Corp $20.64 USD +0.16
Corbion NV €16.79 EUR +0.28
CVR Partners LP $20.57 USD -0.07
Nordion Inc C$12.58 CAD +0.17
Rentech Nitrogen Partners LP $18.12 USD +0.12
View Industry Companies

Industry Analysis


Industry Average

Valuation BCPC Industry Range
Price/Earnings 43.3x
Price/Sales 5.8x
Price/Book 5.7x
Price/Cash Flow 42.5x
TEV/Sales 5.0x

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BALCHEM CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at